$25.07
0.61[2.49%]
At close: Apr 29
$25.07
0[0.00%]
After Hours: 4:00PM EDT
Mirum Pharmaceuticals
(NASDAQ:MIRM)Mirum Pharmaceuticals Stock (NASDAQ:MIRM), Insider Trading Activity
Mirum Pharmaceuticals: Insider buying and selling updated today.
Shares Outstanding
47.118M%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 27, 2024 | ERIC BJERKHOLT | CHIEF FINANCIAL OFFICER | 2K | $24.80 | $49.60K | BUY | 16.67% | 14K | Mar 27 | View |
| Mar 25, 2024 | Peter Radovich | PRESIDENT AND COO | -4.303K | $25.80 | -$111.02K | SELL | -12.92% | 29.013K | Mar 25 | View |
| Mar 18, 2024 | Peter Radovich | PRESIDENT AND COO | -1.379K | $20.62 | -$28.44K | SELL | -3.97% | 33.316K | Jan 09 | View |
| Mar 18, 2024 | Pamela Vig | CHIEF SCIENTIFIC OFFICER | -1.379K | $20.62 | -$28.44K | SELL | -1.33% | 102.312K | Jan 09 | View |
| Mar 18, 2024 | Lara Longpre | CHIEF DEVELOPMENT OFFICER | -38 | $15.63 | -$10.42K | SELL | -0.04% | 104.369K | Sep 10 - Jan 09 | View |
| Mar 18, 2024 | Christopher Peetz | CHIEF EXECUTIVE OFFICER | -5.159K | $20.62 | -$106.39K | SELL | -1.69% | 300.523K | Jan 09 | View |
| Mar 18, 2024 | ERIC BJERKHOLT | CHIEF FINANCIAL OFFICER | 2K | $25.80 | $51.60K | BUY | 20.00% | 12K | Mar 18 | View |
| Feb 05, 2024 | Pamela Vig | CHIEF SCIENTIFIC OFFICER | -1.214K | $26.19 | -$31.80K | SELL | -1.16% | 103.691K | Feb 02 | View |
| Feb 05, 2024 | Lara Longpre | CHIEF DEVELOPMENT OFFICER | -847 | $26.19 | -$22.18K | SELL | -0.80% | 104.407K | Feb 02 | View |
| Feb 05, 2024 | Peter Radovich | PRESIDENT AND COO | -1.79K | $26.19 | -$46.88K | SELL | -4.91% | 34.695K | Feb 02 | View |
| Feb 05, 2024 | Christopher Peetz | CHIEF EXECUTIVE OFFICER | -6.013K | $26.19 | -$157.49K | SELL | -1.93% | 305.682K | Feb 02 | View |
| Feb 02, 2024 | Jolanda Howe | SVP, GLOBAL CONTROLLER | 1.037K | $26.19 | -$19.25K | SELL-OPTIONS | 143.63% | 1.759K | Jan 31 - Feb 02 | View |
| Jan 09, 2024 | Peter Radovich | CHIEF OPERATING OFFICER | -1.408K | $28.03 | -$39.47K | SELL | -3.72% | 36.485K | Jan 08 | View |
| Jan 09, 2024 | Lara Longpre | CHIEF DEVELOPMENT OFFICER | -1.019K | $28.04 | -$28.57K | SELL | -0.96% | 105.254K | Jan 08 | View |
| Jan 09, 2024 | Pamela Vig | HEAD OF RESEARCH & DEVELOPMENT | -1.408K | $28.03 | -$39.47K | SELL | -1.32% | 104.905K | Jan 08 | View |
| Jan 09, 2024 | Christopher Peetz | PRESIDENT AND CEO | -5.209K | $28.03 | -$146.03K | SELL | -1.64% | 311.695K | Jan 08 | View |
| Jan 09, 2024 | Jolanda Howe | SVP, GLOBAL CONTROLLER | 722 | $28.04 | -$14.80K | SELL-OPTIONS | ∞ | 722 | Jan 06 - Jan 08 | View |
| Dec 06, 2023 | Jody Howe | SVP, GLOBAL CONTROLLER | 0 | $17.67 | -$73.65K | SELL-OPTIONS | 0.00% | 0 | Dec 05 | View |
| Nov 14, 2023 | Patrick Heron | DIRECTOR | 2.91K | $28.30 | $82.35K | BUY | 0.08% | 3.728875M | Nov 09 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.